Web Results

Vaso Active Pharmaceuticals, Inc. : Lit. Rel. No. 18834 / August 17 ...


Aug 17, 2004 ... Litigation Release No. 18834 / August 17, 2004. SEC Files Settled Action Charging Vaso Active Pharmaceuticals, Inc. and its President and ...

Declaration of Jerry E. Martin Filed on Behalf of Barrett Johnston ...


Aug 7, 2015 ... action brought against Psychiatric Solutions, Inc., an operator of more than 95 ... United Rubber, Cork, Linoleum & Plastic Workers of America, et al. v. ..... In re: Pharmaceutical Industry .... ·In re Vaso Active Pharmaceuticals,.



Company Name, VASO ACTIVE PHARMACEUTICALS INC. Company Address, 99 ROSEWOOD DRIVE, #260. DANVERS, MA 01923. Company Phone ...

A novel angiotensin-converting enzyme-related carboxypeptidase ...


Sep 1, 2000 ... (1)Millennium Pharmaceuticals, Inc, Cambridge, MA 02139, USA. ... of key vasoactive peptides suggest an essential role for ACE2 in the local ...

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase ...


Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase- activating ... 2002 Wiley-Liss, Inc. INTRODUCTION ... symptoms (Godiska et al., 1995; Karpus and Kennedy,. 1997; Karpus and ... Some of the neuronal-released neuropeptides were re- ported to affect ... linesulfonamide (H89) from ICN Pharmaceuticals.

Pertussis Toxin Blocks the Inhibitory Effects of Somatostatin on ...


0 1986 by The American Society of Biological Chemists, Inc. ... CAMP-dependent Vasoactive Intestinal Peptide and ..... Re- cently, Gershengorn et al. (40) showed that TRH stimulated biphasic .... sources: TRH, Tanabe Pharmaceutical Co.

Chemical synthesis and formulation design of a PEGylated ...


Apr 19, 2013 ... b Peptide Business Development Department, ILS Inc., 1-2-1, Kubogaoka, Moriya, Ibaraki 302-0104, Japan ... Vasoactive intestinal peptide (VIP), an octacosapeptide, is a ... (Onoue et al., 2007), and the respirable powder (RP) formulation ... ylene glycol) (PEG) has become a widely used drug delivery.

Depolarization Increases Vasoactive Intestinal Peptide- and ...


ganglion (SCG) of the adult rat (Hokfelt et al., 1977; Sasek and. Zigmond, 1989). ... synthesis, depolarization of sympathetic neurons has been re- ported to inhibit the .... by adding 1.5 PM veratridine (ICN Pharmaceuticals Inc., Plainview,. NY).

A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of ...


Sep 22, 2014 ... A vasoactive role for relaxin is supported by our recent data that .... ml TriReagent (Ambion Inc., Scoresbury, VIC, Australia) and total RNA was ..... This could have been due to differences in compositional remodeling or re-arrangement of .... 9. van Drongelen J, van Koppen A, Pertijs J, Gooi J, Parry L, et al.

Adrenomedullin, a New Vasoactive Peptide, Is Increased in ...


Adrenomedullin, a New Vasoactive Peptide,. Is Increased in ... vasoactive agents. 3. The role of .... a commercial kit (Phoenix Pharmaceuticals Inc) with rabbit poly- ... Di Iorio et al .... and umbilical vein adrenomedullin concentrations may re-.

Helpful Resources

Vaso Active Pharmaceuticals, Inc., Debtors, Jeoffrey L. Burtch ...


Aug 11, 2014 ... FOR THE DISTRICT OF DELAWARE. In re: ) Chapter 11. ) VASO ACTIVE PHARMACEUTICALS, INC., ). ) Case No. 10-10855 (CSS). Debtors.

Opinion - American Bar Association


Aug 14, 2014 ... In Re: : : PROLIANCE INTERNATIONAL, INC., et al. : Chapter 7 ...... this ruling in In re Vaso Active Pharmaceuticals, Inc.43 Therein, the.

New Value Does Not Need to Remain Unpaid. - Buchanan Ingersoll ...


Oct 29, 2014 ... In In re Proliance International, Inc., et al., Judge Sontchi of the United ... Design, Inc. and In re Vaso Active Pharmaceuticals, Inc., at lease by.

US Court of Appeals, Third Circuit Bankruptcy Cases - Justia


In re: Thomas Giacchi, et al. Filed: November 18 ... In re: National Pool Construction Inc. Filed: October ... Debtor: In re: VASO ACTIVE PHARMACEUTICALS INC.

Cases | A.B. Data Class Action Administration


Beverly Enterprises - Arkansas, Inc., et al. and Vera Cooney and Eula Mae Allen, et al., v. Beverly ...... In re Vaso Active Pharmaceuticals Securities Litigation.